RAYMOND JAMES & ASSOCIATES - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 116 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$683,000
-8.4%
42,662
+2.2%
0.00%0.0%
Q1 2021$746,000
+35.9%
41,748
+2.8%
0.00%0.0%
Q4 2020$549,000
+14.9%
40,622
-0.1%
0.00%0.0%
Q3 2020$478,000
-23.3%
40,653
-3.8%
0.00%0.0%
Q2 2020$623,000
+9.9%
42,240
+0.5%
0.00%0.0%
Q1 2020$567,000
-32.3%
42,025
+21.3%
0.00%0.0%
Q4 2019$837,000
-13.4%
34,636
-31.2%
0.00%0.0%
Q3 2019$967,000
-34.9%
50,317
+0.1%
0.00%
-50.0%
Q2 2019$1,486,000
+40.6%
50,278
+192.7%
0.00%0.0%
Q3 2018$1,057,000
-38.8%
17,175
-32.8%
0.00%
-33.3%
Q2 2018$1,728,000
+25.1%
25,574
+0.5%
0.00%
+50.0%
Q1 2018$1,381,000
-59.4%
25,454
-55.3%
0.00%
-66.7%
Q4 2017$3,399,000
+19.3%
56,894
-3.0%
0.01%0.0%
Q3 2017$2,850,000
-6.2%
58,633
+1.4%
0.01%
-14.3%
Q2 2017$3,040,000
-18.7%
57,841
-29.8%
0.01%
-22.2%
Q1 2017$3,737,000
-14.1%
82,393
-39.8%
0.01%
-18.2%
Q4 2016$4,352,000
-3.6%
136,832
-2.8%
0.01%
-8.3%
Q3 2016$4,515,000
+388.1%
140,729
+167.7%
0.01%
+300.0%
Q2 2016$925,000
+54.7%
52,563
+6.9%
0.00%
+50.0%
Q1 2016$598,000
-53.8%
49,152
-7.5%
0.00%
-60.0%
Q4 2015$1,294,000
+27.5%
53,139
-7.1%
0.01%
+25.0%
Q3 2015$1,015,000
-37.6%
57,196
-37.9%
0.00%
-33.3%
Q2 2015$1,626,000
-3.8%
92,130
+70.8%
0.01%
-14.3%
Q1 2015$1,690,000
+581.5%
53,931
+349.4%
0.01%
+600.0%
Q3 2014$248,00012,0000.00%
Other shareholders

There were no reported owners of AERIE PHARMACEUTICALS INC in Q3 2015.

NameSharesValueWeighting ↓
View complete list of AERIE PHARMACEUTICALS INC shareholders